Dialysis Market Size & Share, by Dialysis Type (Hemodialysis, Peritoneal Dialysis); Type; Disease Indication; End user; Treatment Setting - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

Dialysis Market - Regional Analysis

North America Market Insights

The North America dialysis market is predicted to account for the highest revenue share of 40.4% by the end of the forecast period. The advanced healthcare infrastructure and strong reimbursement systems are the key drivers fueling the region’s leadership. The region hosts major service providers and medical technology firms. As per an article published by Home Dialysis Central in January 2025, there has been a steady growth in home dialysis use over the decade leading up to 2022. Incident patients starting home dialysis rose from 8.5% to 14.5%, whereas PD increased more than home HD. Prevalent patients also saw gains, with PD rising to 12.1% and home HD to 2.4%. Younger, rural, and lower-SDI patients were more likely to use home dialysis. On the other hand, patients with job-based plans and Medicare as a secondary payer had the highest home dialysis rates, hence suitable for bolstering market growth in the region.

U.S. Home Dialysis Facility Distribution by Patient Volume and Modality: 2022 Data

Source: Home Dialysis Central

The higher disease prevalence rates of chronic kidney disease and diabetes, along with a heavy reliance on federal reimbursement programs, are rearranging the growth dynamics of the dialysis market in the U.S. The industry is undergoing a significant transition toward home-based therapies and remote patient monitoring to reduce long-term healthcare costs. According to the report published by the Centers for Disease Control and Prevention in May 2024, about 35.5 million adults in the country, which is 14%, or more than 1 in 7, were affected with CKD in 2023. The report underscored that CKD prevalence increases significantly with age, which affected 34% of adults aged 65 and above, compared to 12% among people aged 45-64 years and 6% in 18-44 years. Therefore, these findings highlight the urgent need for management strategies, i.e., dialysis, to prevent complications such as heart disease and stroke.

The publicly funded healthcare framework, where provincial health authorities manage the majority of renal care services, is responsible for uplifting the dialysis market in Canada. The market is reshaped by a strong focus on enhancing remote patient monitoring and expanding access to care for indigenous communities through telehealth integration. In May 2023, the Government of Saskatchewan and the Saskatchewan Health Authority inaugurated a six-bed satellite hemodialysis unit at the Northwest Health Facility in Meadow Lake. The government invested a total amount of USD 2.6 million in construction and committed USD 700,000 annually for operations, with additional support from the Meadow Lake Tribal Council and Indigenous Services Canada. Hence, such instances in the country indicate the prominence of government-led investments and collaborations in strengthening dialysis infrastructure and accessibility across Canada.

APAC Market Insights

The dialysis market in the Asia Pacific is identified as the fastest-growing sector in the global landscape. The region’s market is primarily propelled by a rising number of affected population and expanding medical access. The countries across the region are making generous investments in terms of dialysis equipment, and local manufacturing initiatives are reducing reliance on foreign-based imports. As stated by the government of Australia in June 2023, Hornsby Ku-ring-gai Hospital introduced renal dialysis services for the first time in its 90-year history as part of a USD 265 million redevelopment. The new 10-chair unit, which has been operational since February 2023, has already delivered over 1,150 treatments and provides care six days a week in just three months. Hence, such satellite units reflect the region’s focus on expanding dialysis infrastructure and improving accessibility, thus supporting the growth potential of the dialysis market.

 A structural shift toward domestic manufacturing and increased government-led healthcare coverage are driving dialysis market expansion in China. Growth is primarily fueled by a strategic national push toward peritoneal dialysis to improve access for patients in rural and underserved regions. In addition, market dynamics are also propelled by Buy China policies that support local medical device companies, as well as a centralized procurement system, which is designed to lower the cost of consumables. According to the January 2025 government data, the country’s health authorities have prioritized expanding hemodialysis services nationwide, and as of the end of 2024, more than 90% of county-level hospitals already offer hemodialysis, reflecting a 20-percentage-point increase when compared to the past decade, hence denoting a positive dialysis market outlook.

India dialysis market is solidifying its presence in the global dynamics owing to the government healthcare schemes, expanding dialysis infrastructure, and technological advancements in renal care. The sector is characterized by a heavy reliance on private providers, along with a gradual push for peritoneal dialysis to overcome the challenges of limited clinical facilities and high travel costs for patients. In February 2024, Odisha Chief Minister dedicated dialysis centers at 16 sub-district hospitals, thereby expanding access to kidney care under the state’s 5T initiative. A total of 32 dialysis centers have been established at the sub-district level, building on the SAHAY scheme, which has provided free, life-saving dialysis services without a heavy financial burden. Hence, such initiatives reflect the prominence of state-led infrastructure expansion and supportive policies, which are strengthening the dialysis ecosystem in India.

Europe Market Insights

The Europe dialysis market is emerging as a mature and highly regulated landscape that benefits from a strong presence of established medical technology firms and a mix of public and private healthcare delivery models. Market dynamics are efficiently fueled by an aging population and a strong R&D ecosystem.  For instance, in May 2024, Fresenius Medical Care presented nearly 40 company-affiliated research abstracts at the 61st Renal Association Congress Europe in Stockholm, thereby highlighting innovations in kidney care with real-world evidence. It also mentions the key findings, including a 23% reduction in mortality with high-volume hemodiafiltration in the CONVINCE study and the use of AI and machine learning to improve hemodialysis outcomes, including predicting hospitalization risk and classifying arteriovenous access aneurysms. Hence, the consistent efforts from domestic pioneers reflect the region’s leadership in advancing dialysis care and its focus on improving patient outcomes.

Germany dialysis market is highly focused on improving a dense network of specialized centers operated by both non-profit organizations and global companies. Value-based care for long-term patient health and efforts on fewer hospital visits are also responsible for uplifting the market. In December, 2024, as per the official press release, the funding for dialysis has been improved to strengthen local access and promote home dialysis under new agreements between the KBV and GKV-Spitzenverband. Reimbursement rates for pediatric dialysis rose by 3.85%, whereas adult dialysis fees increased by 3.0%, with added surcharges to support home-based treatments. New flat-rate fees were introduced, including USD 114 per week for the first year of home dialysis, along with surcharges for peritoneal dialysis, home hemodialysis, and night dialysis. In total, about USD 70.8 million was allocated, with USD 54.5 million directed toward fee increases and the remainder used for structural adjustments, hence denoting a positive market outlook.

A strategic emphasis on cost-efficiency and patient autonomy is responsible for uplifting the UK dialysis market. The country operates as a highly centralized, single-payer system wherein the National Health Service (NHS) serves as the primary provider and purchaser of renal care. In July 2025, the Welsh Kidney Network released an updated home dialysis utility reimbursement toolkit, which helps patients manage rising costs. The toolkit was developed with UKKA, ANN UK, and the Association of Renal Technologists, and it includes a new reimbursement calculator, patient forms, and practice guidelines. Besides, in August, 2024, NHS England issued guidance on a universal dialysis transport support offer to improve patient access. It states that dialysis patients typically require transport three times per week, and the framework allows them to choose flexible options such as public transport, self-driving, or support from relatives, with reimbursement at locally agreed rates, hence suitable for bolstering the market’s development in the country.